检索

期
标题
作者
卷 9, 编号 6 (2023)
Idiopathic pulmonary hypertension (autopsy observation)
Vasyukova O., Tsareva N., Chernyaev A., Mikhaleva L., Samsonova M.
PDF
(Rus)
卷 9, 编号 6 (2023)
Pathogenetic therapy of pulmonary hypertension
Tsareva N., Khachaturov M., Avdeev S.
PDF
(Rus)
卷 9, 编号 1 (2023)
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (memo): subanalysis in patients with arterial hypertension
Zakharov V., Ostroumova O., Kochetkov A., Klepikova M., Fedin A.
PDF
(Rus)
卷 9, 编号 1 (2023)
Predictors of cardiovacular risk as prognostic factors of adverse course and outcomes of COVID-19 in young and middle age adults
Bratilova E., Kachnov V., Tyrenko V., Afonaskov O.
PDF
(Rus)
卷 9, 编号 8 (2023)
Influence of vascular remodelling and reduced heart rate variability at indapamide efficacy in patients with arterial hypertension
Iskenderov B., Lokhina T., Mozhzhukhina I., Berenshtein N., Zaitseva A.
PDF
(Rus)
卷 9, 编号 8 (2023)
Treatment of comorbid patients over 80 years old: focus at arterial hypertension (analysis of real clinical practice)
Safronenko V., Chesnikova A.
PDF
(Rus)
卷 10, 编号 1 (2024)
Gender peculiarities of clinical manifestations in patients with arterial hypertension and chronic heart failure in combination with senile asthenia syndrome
Safronenko V., Chesnikova A.
PDF
(Rus)
卷 9, 编号 10 (2023)
Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders»
Martynov A., Tanashyan M., Malyavin A., Bogolepova A., Borovkova N., Eliseeva L., Zhuravleva M., Zakharov V., Koryagina N., Mikhin V., Osipova I., Ostroumova O., Pozdnyak A., Portnyagina U., Statsenko M., Tyrenko V., Chesnikova A.
PDF
(Rus)
卷 9, 编号 8 (2023)
Correction of risk factors in patients with atrial fibrillation
Prekina V., Kunyaeva T., Shokina S., Samolkina O., Skopina Y.
PDF
(Rus)
卷 9, 编号 10 (2023)
24-hour blood pressure monitoring during treatment with free and fixed combinations of antihypertensive drugs
Gumerov F., Mayanskaya S., Malysheva E.
PDF
(Rus)
卷 9, 编号 8 (2023)
More on the neuroprotectory therapy evidential base: focus at ethylmethyl hydroxypyridine succinate
Kochetkov A., Shatalova N., Klepikova M., Filippova T., Ostroumova O.
PDF
(Rus)
卷 9, 编号 8 (2023)
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors
Usanova A., Lavrenova E., Kunyaeva T., Kuzma F., Novikova E., Sergutova N., Chatkina T.
PDF
(Rus)
卷 9, 编号 4 (2023)
Indapamide in the treatment of arterial hypertension
Syrov A.
PDF
(Rus)
卷 10, 编号 2 (2024)
Polymorphic variants of renin-angiotensin-aldosterone system genes in female patients with a history of arterial hypertension during pregnancy and their association with metabolic syndrome
Tarasova O., Chulkov V., Ektova N., Chulkov V.
PDF
(Rus)
卷 9, 编号 5 (2023)
Clinical case of a comorbid patient with ischemic brain stroke
Kobzeva N., Gelpey M., Zibrova L., Skoropis A., Shchetinkina D.
PDF
(Rus)
卷 9, 编号 3 (2023)
Risk factors, prevalence and rates of chronic kidney disease progression in outpatient patients with arterial hypertension
Sigitova O., Bogdanova A., Saubanova E.
PDF
(Rus)
编号 1 (2017)
Is there a relationship between bronchial asthma and arterial hypertension?
Kuznetsov A., Grigorieva N., Ilyushina T., Mayorova M.
PDF
(Rus)
卷 7, 编号 5 (2021)
Treatment of arterial hypertension I-II stages in patients with risk of cardiovascular complications above moderate in real clinical practice: possibilities of indapamide in a combined therapy
Trukhan D., Filimonov S.
PDF
(Rus)
卷 8, 编号 1 (2022)
Arterial hypertension and smoking: what a therapist should know
Korneeva N.
PDF
(Rus)
编号 3 (2016)
ARTERIAL HYPERTENSION AND CHRONIC BRONCHOPULMONARY DISEASES
Grigorieva N., Kuznetsov A.
PDF
(Rus)
编号 4 (2016)
Prospects for the use of moxonidine (Physiotens®) in the prevention of bone resorption and aging of the vascular wall
Dudinskaya Y., Tkacheva O.
PDF
(Rus)
编号 1 (2018)
Dayly dynamics of indices of central aortic pressure and arterial stiffness in patients with arterial hypertension in the composition of a metabolic syndrome at the background of a fixed-dose combination of perindopril arginine and indapamide
Andreeva L., Panchenkova L., Martynov A., Troshina E., Khamidova K., Kazanceva E., Medvedeva L., Karnuta G., Yurkova T.
PDF
(Rus)
编号 4 (2016)
Peculiarities of arterial hypertension in patients with acromegaly in active phase
Zaviyalova Y., Borovkov N., Zanozina O., Borovkova N.
PDF
(Rus)
编号 4 (2018)
The efficacy of angiotensin II receptors’ blockers use in patients wkth arterial hypertension and metabolic syndrome
Evdokimova A., Kovalenko Y., Evdokimov V., Tebloev K.
PDF
(Rus)
编号 6 (2017)
Possibilities of fixed combination of nitrendipine and enalapril in the treatment of arterial hypertension
Batishcheva G., Mubarakshina O., Somova M., Yevstigneeva A.
PDF
(Rus)
编号 1 (2016)
THE ABILITY OF TORASEMIDE FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE
Statsenko M., Turkina S.
PDF
(Rus)
卷 8, 编号 8 (2022)
Estimation of central aortic pressure in patients with arterial hypertension and atherosclerosis of the arteries of the lower extremities
Sementsova N., Chesnikova A., Safronenko V., Skarzhinskaya N.
PDF
(Rus)
卷 7, 编号 9 (2021)
Clinical significance of gene polymorphisms in the development of metabolic syndrome in the young population
Korneeva E., Voevoda M., Semaev S., Maksimov V.
PDF
(Rus)
编号 4 (2018)
Possibility ofhigh-selective adrenoblockers use in combined therapy of patients with metabolic syndrome
Tolpygina S.
PDF
(Rus)
编号 5 (2017)
Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications
Yermakova Y., Kochergina I.
PDF
(Rus)
编号 1 (2015)
CARDIOVASCULAR DISEASES AT THE PREHOSPITAL STAGE: HOW TO IMPROVE THE EFFECTIVENESS OF CARE?
Mychka V., Uzueva E.
PDF
(Rus)
卷 8, 编号 8 (2022)
The incidence of abdominal obesity and its association with risk factors for cardiovascular disease in middle-aged people
Larina V., Fedorova E., Sayno O., Mironova T., Orlov D.
PDF
(Rus)
卷 8, 编号 5 (2022)
New criteria for long-term CPAP therapy adherence in obstructive sleep apnea syndrome and arterial hypertension patients
Ovchinnikov Y., Mostovoy L., Zaitsev A.
PDF
(Rus)
编号 6 (2016)
Clinical efficacy of fixed-dose combination antihypertensive therapy (focus on Hypotef)
Yevdokimova A., Yevdokimov V., Kovalenko Y., Tebloyev K.
PDF
(Rus)
编号 4 (2016)
Angiotensin II receptor blockers: focus on cardesartan
Cheltsov V., Gushina Y., Illarioniva T., Korovyakova E., Moiseeva A., Pereversev A., Stefanenko Y., Ziryanov S.
PDF
(Rus)
编号 1 (2015)
EXPERIENCE WITH THE USE OF MELDONIUM IN LONG IMMOBILIZED PATIENTS WITH CEREBROVASCULAR DISEASES
Shevtsova V., Vertkin A.
PDF
(Rus)
编号 5 (2016)
Pharmacoepidemiological study of ethnic differences in the use of antihypertensive drugs for hospital treatment of residents of the Karachay-Cherkess Republic
Baturin V., Elkanova A.
PDF
(Rus)
编号 4S (2022): Supplement
The special role of melatonin in the development of hypertension
Rezova N., Pertsev A., Shkatova Y.
PDF
(Rus)
卷 8, 编号 4 (2022)
DRUG SAFETY AND POLYMORBIDITY AS IMPORTANT COMPONENTS OF RATIONAL PHARMACOTHERAPY IN CARDIOLOGY
Polyakova O., Ostroumova O., Arablinsky A.
PDF
(Rus)
编号 8 (2017)
THE ADVANTAGES OF USING FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS IN CLINICAL PRACTICE
Lukina Y.
PDF
(Rus)
编号 4 (2017)
PREVENTION AND TREATMENT OF COGNITIVE DISORDERS IN PATIENTS WITH HYPERTENSIVE ENCEPHALOPATHY
YEVDOKIMOVA A., KIPARISOVA Y., KOVALENKO Y., YEVDOKIMOV V., MARKOVA L., TEBLOEV K., LARINA I., MARTYNOV A.
PDF
(Rus)
编号 4S (2022): Supplement
Quality of life of patients with arterial hypertension including in standard antihypertensive pharmacotherapy quercetin/dihydroquercetin
Nalotov S., Nalotova O., Korovka I., Nalotova E., Alesinsky M., Tverdochleb T.
PDF
(Rus)
卷 8, 编号 3 (2022)
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
Derevyanchenko M., Fedotov V., Shaposhnikova M., Kolodin S.
PDF
(Rus)
卷 7, 编号 5 (2021)
Clinical case: interstitial pulmonary fibrosis in systemic sclerosis
Konyukova A., Pechnikova V., Vasyukova O., Ananieva L., Cherniaev A., Samsonova M.
PDF
(Rus)
编号 6 (2017)
Rational therapy of hypertensive crisis in the light of modern recommendations
Lyamina N., Nalivaeva A.
PDF
(Rus)
编号 2 (2017)
Such different sartans. Place of candesartan
Shaposhnik I.
PDF
(Rus)
编号 5 (2016)
Torasemide and furosemide: similarities and differences
Cheltsov V.
PDF
(Rus)
卷 8, 编号 9 (2022)
ELDERLY PATIENT WITH ARTERIAL HYPERTENSION: FOCUS AT THERAPY INDIVIDUALIZATION
Kotovskaya Y.
PDF
(Rus)
卷 8, 编号 1 (2022)
Treatment of arterial hypertension in high risk comorbid patients: possibilities of amlodipine and losartan combination
Larina V.
PDF
(Rus)
编号 6 (2018)
Correction of symptoms of meteosensitivity in arterial hypertension patients
Kislyak O., Kasatova T., Postnikova S.
PDF
(Rus)
编号 6 (2017)
Influence of antihypertensive therapy at endotheline-1 level in arterial hypertensive patients
Mammayev S., Ibragimova K.
PDF
(Rus)
编号 2 (2017)
Potentials for the use of diuretic therapy in the clinic of internal diseases
Yevdokimova A., Kovalenko Y., Yevdokimov V., Shuiskaya O.
PDF
(Rus)
编号 5 (2016)
Place of eplerenone in the therapy of cardiovascular diseases
Tolpygina S.
PDF
(Rus)
卷 8, 编号 10 (2022)
Arterial hypertension and longevity
Reznik E., Golubev Y., Zhuravlev A., Yurtaeva N., Ischenko G.
PDF
(Rus)
卷 8, 编号 1 (2022)
A case of diagnostics of IgG4-related disease with primary renal damage and secondary arterial hypertension
Vladimirova N., Myasnikova E., Beketova T., Peredelkina A., Shunaev V., Pikunova I.
PDF
(Rus)
编号 6 (2017)
Features of use of angiotensin receptor blockers in clinical practice (focus on candesartan)
Evdokimova A., Kovalenko Y., Evdokimov V., Tebloev K., Shvetsova I.
PDF
(Rus)
编号 1 (2017)
System analysis of endothelium dysfunction in pat with arterial hypertension, the inhabitants of highlands
Kurdanova M., Martynov A., Beslaneev I., Batyrbekova L., Kurdanov H.
PDF
(Rus)
编号 5 (2016)
Influence of magnesium orotate on cardiovascular risks
Martynov A., Akatova Y., Nikolin O., Urlaeva I.
PDF
(Rus)
卷 8, 编号 9 (2022)
Arterial hypertension and posterior reversible encephalopathy syndrome
Martynov M., Gudkova V., Koltsova E., Razinskaya O., Abramenkova N., Solntsev E., Ulyanov D., Chuprina S.
PDF
(Rus)
1 - 59 的 59 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##